Reprogramming- and pluripotency-associated membrane proteins in mouse stem cells revealed by label-free quantitative proteomics

Journal of Proteomics

Volumn 86, Issue , 2013, Pages 70-84

  Hao, Jie ^a,b   Li, Wei ^b   Dan, Jiameng ^a   Ye, Xiaoying ^a   Wang, Fang ^a   Zeng, Xinhai ^b   Wang, Lei ^a   Wang, Huiyong ^c   Cheng, Yang ^b   Liu, Lin ^a   Shui, Wenqing ^a,b  

^a NANKAI UNIVERSITY   (China)

^b High throughput Molecular Drug Discovery Center   (China)

^c ZhongXin Biotechology Shanghai Co Ltd   (China)

Author keywords

Embryonic stem cell (ESC); Induced pluripotent stem cell (iPSC); Label free quantitation; Membrane proteomics; Reprogramming; Stem cell pluripotency

Indexed keywords

AMINO ACID; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; ION; MEMBRANE PROTEIN; TRANSFERRIN RECEPTOR;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYONIC STEM CELL; FRACTIONATION; GLUCOSE TRANSPORT; ION TRANSPORT; MASS SPECTROMETRY; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; RAT; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ANIMALS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FIBROBLASTS; GENE KNOCKDOWN TECHNIQUES; GENE ONTOLOGY; GLUCOSE TRANSPORTER TYPE 3; INDUCED PLURIPOTENT STEM CELLS; MASS SPECTROMETRY; MEMBRANE PROTEINS; MICE; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS; PROTEOMICS; TAIL; TRANSCRIPTOME;

EID: 84878925851     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.04.018     Document Type: Article

References (58)

1. Reiland S., Salekdeh G.H., Krijgsveld J. Defining pluripotent stem cells through quantitative proteomic analysis. Expert Rev Proteomics 2011, 8:29-42.
2. Yu J., et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009, 324:797-801.
3. Takahashi K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
4. Taura D., et al. Adipogenic differentiation of human induced pluripotent stem cells: comparison with that of human embryonic stem cells. FEBS Lett 2009, 583:1029-1033.
5. Marchetto M.C., et al. Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS One 2009, 4:e7076.
6. Chin M.H., et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009, 5:111-123.
7. Guenther M.G., et al. Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 2010, 7:249-257.
8. Mann M. Functional and quantitative proteomics using SILAC. Nat Rev Mol Cell Biol 2006, 7:952-958.
9. Kovanich D., et al. Applications of stable isotope dimethyl labeling in quantitative proteomics. Anal Bioanal Chem 2012, 404:991-1009.
10. Huang X., et al. Quantitative proteomic analysis of mouse embryonic fibroblasts and induced pluripotent stem cells using 16O/18O labeling. J Proteome Res 2012, 11:2091-2102.
11. Graumann J., et al. Stable isotope labeling by amino acids in cell culture (SILAC) and proteome quantitation of mouse embryonic stem cells to a depth of 5,111 proteins. Mol Cell Proteomics 2008, 7:672-683.
12. Prokhorova T.A., et al. Stable isotope labeling by amino acids in cell culture (SILAC) and quantitative comparison of the membrane proteomes of self-renewing and differentiating human embryonic stem cells. Mol Cell Proteomics 2009, 8:959-970.
13. Van Hoof D., et al. A quest for human and mouse embryonic stem cell-specific proteins. Mol Cell Proteomics 2006, 5:1261-1273.
14. Rigbolt K.T., et al. System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci Signal 2011, 4:rs3.
15. Munoz J., et al. The quantitative proteomes of human-induced pluripotent stem cells and embryonic stem cells. Mol Syst Biol 2011, 7:550.
16. Phanstiel D.H., et al. Proteomic and phosphoproteomic comparison of human ES and iPS cells. Nat Methods 2011, 8:821-827.
17. Chae J.I., et al. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient. Biochem J 2012, 446:359-371.
18. Harkness L., et al. Identification of a membrane proteomic signature for human embryonic stem cells independent of culture conditions. Stem Cell Res 2008, 1:219-227.
19. McQuade L.R., Schmidt U., Pascovici D., Stojanov T., Baker M.S. Improved membrane proteomics coverage of human embryonic stem cells by peptide IPG-IEF. J Proteome Res 2009, 8:5642-5649.
20. Dormeyer W., et al. Plasma membrane proteomics of human embryonic stem cells and human embryonal carcinoma cells. J Proteome Res 2008, 7:2936-2951.
21. Gao B.B., Stuart L., Feener E.P. Label-free quantitative analysis of one-dimensional PAGE LC/MS/MS proteome: application on angiotensin II-stimulated smooth muscle cells secretome. Mol Cell Proteomics 2008, 7:2399-2409.
22. Chen Z., et al. Birth of parthenote mice directly from parthenogenetic embryonic stem cells. Stem Cells 2009, 27:2136-2145.
23. Wang F., et al. Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells. Cell Res 2012, 22(4):757-768.
24. Okita K., Ichisaka T., Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448:313-317.
25. Shevchenko A., Tomas H., Havlis J., Olsen J.V., Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 2006, 1:2856-2860.
26. Silva J.C., et al. Quantitative proteomic analysis by accurate mass retention time pairs. Anal Chem 2005, 77:2187-2200.
27. Shen Z., et al. Label-free quantitative proteomics analysis of etiolated maize seedling leaves during greening. Mol Cell Proteomics 2009, 8:2443-2460.
28. Maltsev V.A., Wobus A.M., Rohwedel J., Bader M., Hescheler J. Cardiomyocytes differentiated in vitro from embryonic stem cells developmentally express cardiac-specific genes and ionic currents. Circ Res 1994, 75:233-244.
29. Huang J., et al. Association of telomere length with authentic pluripotency of ES/iPS cells. Cell Res 2011, 21:779-792.
30. Dormeyer W., van Hoof D., Mummery C.L., Krijgsveld J., Heck A.J. A practical guide for the identification of membrane and plasma membrane proteins in human embryonic stem cells and human embryonal carcinoma cells. Proteomics 2008, 8:4036-4053.
31. Xu D., et al. Novel MMP-9 substrates in cancer cells revealed by a label-free quantitative proteomics approach. Mol Cell Proteomics 2008, 7:2215-2228.
32. Wright C.A, et al. Label-free quantitative proteomics reveals differentially regulated proteins influencing urolithiasis. Mol Cell Proteomics 2011, 10. M110 005686.
33. Folmes C.D., et al. Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metab 2011, 14:264-271.
34. Lu R., et al. Systems-level dynamic analyses of fate change in murine embryonic stem cells. Nature 2009, 462:358-362.
35. Li X., et al. Developmental expression of sideroflexin family genes in Xenopus embryos. Dev Dyn 2010, 239:2742-2747.
36. Chaerkady R., et al. Comparative proteomics of human embryonic stem cells and embryonal carcinoma cells. Proteomics 2010, 10:1359-1373.
37. Jin J., et al. Analysis of differential proteomes of induced pluripotent stem cells by protein-based reprogramming of fibroblasts. J Proteome Res 2011, 10:977-989.
38. Segev H., Fishman B., Schulman R., Itskovitz-Eldor J. The Expression of the Class 1 Glucose Transporter Isoforms in Human Embryonic Stem Cells, and the Potential Use of GLUT2 as a Marker for Pancreatic Progenitor Enrichment. Stem Cells Dev 2012, 21:1653-1661.
39. Tonack S., Rolletschek A., Wobus A.M., Fischer B., Santos A.N. Differential expression of glucose transporter isoforms during embryonic stem cell differentiation. Differentiation 2006, 74:499-509.
40. Knelangen J.M., Kurz R., Schagdarsurengin U., Fischer B., Navarrete Santos A. Short-time glucose exposure of embryonic carcinoma cells impairs their function as terminally differentiated cardiomyocytes. Biochem Biophys Res Commun 2012, 420:230-235.
41. Ganguly A., et al. Glucose transporter isoform-3 mutations cause early pregnancy loss and fetal growth restriction. Am J Physiol Endocrinol Metab 2007, 292:E1241-1255.
42. Li L., Bennett S.A., Wang L. Role of E-cadherin and other cell adhesion molecules in survival and differentiation of human pluripotent stem cells. Cell Adh Migr 2012, 6:222-233.
43. Li L., et al. A unique interplay between Rap1 and E-cadherin in the endocytic pathway regulates self-renewal of human embryonic stem cells. Stem Cells 2010, 28:247-257.
44. Li L., et al. Individual cell movement, asymmetric colony expansion, rho-associated kinase, and E-cadherin impact the clonogenicity of human embryonic stem cells. Biophys J 2010, 98:2442-2451.
45. Chen G., Hou Z., Gulbranson D.R., Thomson J.A. Actin-myosin contractility is responsible for the reduced viability of dissociated human embryonic stem cells. Cell Stem Cell 2010, 7:240-248.
46. Ohgushi M., et al. Molecular pathway and cell state responsible for dissociation-induced apoptosis in human pluripotent stem cells. Cell Stem Cell 2010, 7:225-239.
47. Redmer T., et al. E-cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming. EMBO Rep 2011, 12:720-726.
48. Chen T., et al. E-cadherin-mediated cell-cell contact is critical for induced pluripotent stem cell generation. Stem Cells 2010, 28:1315-1325.
49. Eastham A.M., et al. Epithelial-mesenchymal transition events during human embryonic stem cell differentiation. Cancer Res 2007, 67:11254-11262.
50. Huang H.P., et al. Epithelial cell adhesion molecule (EpCAM) complex proteins promote transcription factor-mediated pluripotency reprogramming. J Biol Chem 2011, 286:33520-33532.
51. Xu Y., et al. Revealing a core signaling regulatory mechanism for pluripotent stem cell survival and self-renewal by small molecules. Proc Natl Acad Sci U S A 2010, 107:8129-8134.
52. Gerke V., Creutz C.E., Moss S.E. Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 2005, 6:449-461.
53. Dechat T., Adam S.A., Taimen P., Shimi T., Goldman R.D. Nuclear lamins. Cold Spring Harb Perspect Biol 2010, 2:a000547.
54. Vergnes L., Peterfy M., Bergo M.O., Young S.G., Reue K. Lamin B1 is required for mouse development and nuclear integrity. Proc Natl Acad Sci U S A 2004, 101:10428-10433.
55. Kim Y., et al. Mouse B-type lamins are required for proper organogenesis but not by embryonic stem cells. Science 2011, 334:1706-1710.
56. Farhan H., Hauri H.P. Membrane biogenesis: networking at the ER with atlastin. Curr Biol 2009, 19:R906-908.
57. Bharti P., et al. PEX14 is required for microtubule-based peroxisome motility in human cells. J Cell Sci 2011, 124:1759-1768.
58. Munro S. The golgin coiled-coil proteins of the Golgi apparatus. Cold Spring Harb Perspect Biol 2011, 3.